US 9249179
Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA
granted A61PA61P1/16A61P3/00
Quick answer
US patent 9249179 (Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA) held by Arrowhead Madison, Inc. expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Madison, Inc.
- Grant date
- Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P1/16, A61P3/00, A61P31/12